Millicent Animley, FNP-C

Millicent Animley practices at Gastroenterology Associates of Northern Virginia in Fairfax, Virginia.

Millicent Animley's NPI, 1760104913, was assigned on September 14, 2022. Millicent Animley holds Virginia license 0024185221.

Millicent Animley's primary practice is Gastroenterology Associates of Northern Virginia, at 3700 Joseph Siewick Dr, Fairfax, VA 22033 in Fairfax County. The practice phone is (703) 716-8700.

Millicent Animley's primary practice is Gastroenterology Associates of Northern Virginia in Fairfax, Virginia. Millicent Animley is also affiliated with Inova Fairfax Hospital. The medical group on file is Signify Health. Dmand AI also links Millicent Animley to 3 more hospitals, 4 medical groups, 2 group practices and clinics and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Millicent Animley practices, 7 sites in all. Vendor and product names are available with a free account.

Family is Millicent Animley's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Millicent Animley is licensed in Virginia.

CMS counts 371 Medicare patients who saw Millicent Animley in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Millicent Animley's median patient age at 59, with 62% women.

In 2024, Millicent Animley wrote 1,061 Medicare Part D claims for 208 patients. 88% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Millicent Animley for performance year 2024, reported as part of a group. Millicent Animley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 82 general payments to Millicent Animley from 20 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $274.